Healthcare -
Biotechnology - NASDAQ - US
$ 4.14
-2.62 %
$ 178 M
Market Cap
-6.39
P/E
DMAC - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities DMAC - DiaMedica Therapeutics Inc.
8.56 M
LAST VALUE
-13.85%
2 YEAR CAGR
33.19%
5 YEAR CAGR
75.38%
10 YEAR CAGR